aztreonam has been researched along with Multiple Myeloma in 1 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "One hundred and nine patients with infection accompanying hematologic disorders including leukemia and lymphoma were treated with aztreonam (AZT)." | 3.67 | [Therapeutic effectiveness of aztreonam on severe infections associated with hematologic disorders. Hanshin Infection Study Group]. ( Hirayama, F; Horiuchi, A; Kawagoe, H; Kitani, T; Masaoka, T; Nagai, K; Okamoto, Y; Shibata, H; Yasunaga, K; Yonezawa, T, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirayama, F | 1 |
| Masaoka, T | 1 |
| Shibata, H | 1 |
| Nagai, K | 1 |
| Kitani, T | 1 |
| Horiuchi, A | 1 |
| Kawagoe, H | 1 |
| Yasunaga, K | 1 |
| Okamoto, Y | 1 |
| Yonezawa, T | 1 |
1 other study available for aztreonam and Multiple Myeloma
| Article | Year |
|---|---|
[Therapeutic effectiveness of aztreonam on severe infections associated with hematologic disorders. Hanshin Infection Study Group].
Topics: Adolescent; Adult; Aged; Aztreonam; Bacterial Infections; Drug Evaluation; Drug Resistance, Microbia | 1985 |